πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8546091

AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546524

Smoothened polypeptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8545888

Tendon stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8536148

Disabling autophagy as a treatment for lysosomal storage diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8530167

Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524248

Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524239

Photosensitizing antibody-fluorophore conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8518968

Hydrazone and diacyl hydrazine compounds and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8518957

Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing in

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8512991

Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, composition

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8506961

Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501912

Filipil compositions and methods for treating cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501688

SCGB3A2 as a growth factor and anti-apoptotic agent

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8481255

Scytovirin domain 1 related polypeptides

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8470888

Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8465743

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of s

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8460675

Viral chemokine-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454936

Metal chelators and methods of their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8455454

miR 204, miR 211, their anti-miRs, and therapeutic uses of same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454972

Method for inducing a multiclade immune response against HIV utilizing a multigene and mul

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8450325

Methods for reducing the recurrence of cardiac arrhythmia

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8444996

Multicomponent vaccine for malaria providing long-lasting immune responses against plasmod

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440415

BORIS isoforms and methods of detecting and treating disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431690

T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted